This resource was approved by the SMI Adviser clinical expert team for inclusion in the knowledge base.
This is a journal article from Schizophrenia Bulletin. Clozapine was found to be the only antipsychotic associated with decreased risk of attempted or completed suicide among patients with schizophrenia, and it should be considered as first-line treatment for high-risk patients.